CVRX
CVRx, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$1.35
+3.85%Year over year
Reported trailing growth
- Revenue
- +12.0%
- EBITDA
- +2.2%
- EBIT
- +4.8%
- EPS
- +5.7%
- Free cash flow
- -4.1%
- Operating cash flow
- -3.4%
Forward estimates
Based on analyst estimates
- Revenue
- +3.1%
- EBITDA
- +0.3%
- EPS
- +0.7%
Three-year CAGR
- Revenue
- +36.1%
- EBITDA
- +14.9%
- EBIT
- +13.8%
- Net income
- +11.1%
- EPS
- +23.0%
- Free cash flow
- -0.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026